CD274 and neoplasm: Coherently with this picture, the combination of anti-angiogenic drugs with anti-PD-L1 therapies increases HEV and TLS formation in murine models of breast cancer and neuroendocrine pancreatic tumors [90], supporting the idea that a powerful anti-tumor systemic response by ICIs is sustained, if not triggered, by the presence of TLSs in situ.